93% overall response and 76% complete response rates with median progression-free survival of 18 months in patients with large B-cell…
Genesis Magma Racing complete driver lineup for 2026 FIA World Endurance Championship with Mathieu Jaminet and Paul-Loup Chatin The two drivers…
SANTA CLARA, Calif. and MARIA ENZERSDORF, Austria, Nov. 4, 2025 /PRNewswire/ -- Picarro Inc., in collaboration with Netz Niederösterreich (Netz NÖ),…
SAN FRANCISCO, Oct. 26, 2025 /PRNewswire/ -- At the 2025 Transcatheter Cardiovascular Therapeutics® (TCT) Conference, Dr. Jarrod Frizzell of The…
DUBLIN and STAMFORD, Conn. and SALT LAKE CITY, Oct. 14, 2025 /PRNewswire/ -- AIP Capital ("AIP"), an alternative investment manager…
Bigg Boss 19 Episode 33 Review: Awez’s Task, Tanya–Kunika Clash, Nehal’s Entry and Gaurav as New Captain https://youtu.be/oDnnZdvG6AI The latest…
MINNEAPOLIS, Aug. 13, 2025 /PRNewswire/ -- A recent study published in the Journal of the Society for Cardiovascular Angiography & Interventions…
Aliya Capital Partners and Protego Ventures Co-Lead Strategic Series B Round alongside participating investors: Len Blavatnik's Claltech, Union-Tech Ventures &…
July 11, 2025 16:30 ET | Source: Ultragenyx Pharmaceutical Inc. Complete Response Letter (CRL) cited specific chemistry, manufacturing and controls…
Of the 34 patients enrolled in Cohort 3 of the ATALANTA-1 Phase 1/2 study, 32 received GLPG5101; 94% were infused…